NV-387 has completed Phase I clinical trial for safety and … “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange …
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66cc6cf2e4e24ff888ac59f082954f79&url=https%3A%2F%2Fwww.kansascity.com%2Fpress-releases%2Farticle291473705.html&c=7024554963868447872&mkt=en-us
Author :
Publish date : 2024-08-25 19:30:00
Copyright for syndicated content belongs to the linked Source.